Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Rouvet

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 23, 2013
⁹⁹mTc-(Me)FGCDEVD, a potential tracer for apoptosis detectionPierre Bohn, Florian Mouchard, Jean Rouvet, et al.
Pharmacotherapy|January 30, 2013
Preliminary validation of self-assessment tool to measure imatinib adherence in patients with chronic myeloid leukemiaMikael Daouphars, Marine Ouvry, Pascal Lenain, et al.
European Journal of Hospital Pharmacy : Science and Practice|June 4, 2019
Physicochemical stability of oxycodone-ketamine solutions in polypropylene syringe and polyvinyl chloride bag for patient-controlled analgesia useMikaël Daouphars, Charles-Henri Hervouët, Pierre Bohn, et al.
Breast Cancer Research and Treatment|April 22, 2025
Impact of pembrolizumab on ovarian function in young triple-negative breast cancer patients treated with chemo-immunotherapyAnne Perdrix, Nathalie Olympios, Jean Rouvet, et al.
Nuclear Medicine Communications|May 9, 2013
Biodistribution and imaging of [99mTc]-HYNIC-RGD in MDA-MB-231 and NTERA-2 cancer cell xenograftsPierre Bohn, Romain Modzelewski, Jean Rouvet, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 1, 2010
αvβ3 imaging can accurately distinguish between mature teratoma and necrosis in 18F-FDG-negative residual masses after treatment of non-seminomatous testicular cancer: a preclinical studyNicolas Aide, Mélanie Briand, Pierre Bohn, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 3, 2025
Prognostic value of circulating HER2 extracellular domain in patients with HER2-positive metastatic breast carcinoma treated with TDM-1 (trastuzumab emtansine)Roman Vion, Céline Calbrix, Anca Berghian, et al.
Fundamental & Clinical Pharmacology|January 30, 2020
Deleterious impact of a generic temozolomide formulation compared with brand-name product on the kinetic of platelet concentration and survival in newly diagnosed glioblastomaMaxime Fontanilles, Adeline Fontanilles, Nathalie Massy, et al.
Hematological Oncology|October 7, 2025
Routine Monitoring of CAR-T-Cells Expansion and Persistence in Patients With Aggressive Large B-Cell Lymphoma by Flow Cytometry: A Single-Center ExperienceAlexandra Zduniak, Jérémie Martinet, Emilie Lévêque, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|January 23, 2013
⁹⁹mTc-(Me)FGCDEVD, a potential tracer for apoptosis detectionPierre Bohn, Florian Mouchard, Jean Rouvet, et al.
Pharmacotherapy|January 30, 2013
Preliminary validation of self-assessment tool to measure imatinib adherence in patients with chronic myeloid leukemiaMikael Daouphars, Marine Ouvry, Pascal Lenain, et al.
European Journal of Hospital Pharmacy : Science and Practice|June 4, 2019
Physicochemical stability of oxycodone-ketamine solutions in polypropylene syringe and polyvinyl chloride bag for patient-controlled analgesia useMikaël Daouphars, Charles-Henri Hervouët, Pierre Bohn, et al.
Breast Cancer Research and Treatment|April 22, 2025
Impact of pembrolizumab on ovarian function in young triple-negative breast cancer patients treated with chemo-immunotherapyAnne Perdrix, Nathalie Olympios, Jean Rouvet, et al.
Nuclear Medicine Communications|May 9, 2013
Biodistribution and imaging of [99mTc]-HYNIC-RGD in MDA-MB-231 and NTERA-2 cancer cell xenograftsPierre Bohn, Romain Modzelewski, Jean Rouvet, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 1, 2010
αvβ3 imaging can accurately distinguish between mature teratoma and necrosis in 18F-FDG-negative residual masses after treatment of non-seminomatous testicular cancer: a preclinical studyNicolas Aide, Mélanie Briand, Pierre Bohn, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 3, 2025
Prognostic value of circulating HER2 extracellular domain in patients with HER2-positive metastatic breast carcinoma treated with TDM-1 (trastuzumab emtansine)Roman Vion, Céline Calbrix, Anca Berghian, et al.
Fundamental & Clinical Pharmacology|January 30, 2020
Deleterious impact of a generic temozolomide formulation compared with brand-name product on the kinetic of platelet concentration and survival in newly diagnosed glioblastomaMaxime Fontanilles, Adeline Fontanilles, Nathalie Massy, et al.
Hematological Oncology|October 7, 2025
Routine Monitoring of CAR-T-Cells Expansion and Persistence in Patients With Aggressive Large B-Cell Lymphoma by Flow Cytometry: A Single-Center ExperienceAlexandra Zduniak, Jérémie Martinet, Emilie Lévêque, et al.
Pageof 1